• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

High acceptance rate of COVID-19 vaccination in liver transplant recipients.

作者信息

Giannini Edoardo G, Marenco Simona

机构信息

Gastroenterology Unit, Department of Internal Medicine, University of Genoa, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.

Gastroenterology Unit, Department of Internal Medicine, University of Genoa, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.

出版信息

J Hepatol. 2021 Aug;75(2):483-484. doi: 10.1016/j.jhep.2021.05.009. Epub 2021 May 28.

DOI:10.1016/j.jhep.2021.05.009
PMID:34052253
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8159704/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/addf/8159704/0e989ace51fa/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/addf/8159704/0e989ace51fa/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/addf/8159704/0e989ace51fa/gr1_lrg.jpg

相似文献

1
High acceptance rate of COVID-19 vaccination in liver transplant recipients.肝移植受者对新冠病毒疫苗的高接种率
J Hepatol. 2021 Aug;75(2):483-484. doi: 10.1016/j.jhep.2021.05.009. Epub 2021 May 28.
2
Acceptance of SARS-CoV-2 vaccines by liver transplant recipients and candidates.肝移植受者和候选者对 SARS-CoV-2 疫苗的接受情况。
Z Gastroenterol. 2021 Dec;59(12):1288-1296. doi: 10.1055/a-1649-8568. Epub 2021 Oct 20.
3
Liver injury after mRNA-based SARS-CoV-2 vaccination in a liver transplant recipient.一名肝移植受者接种基于mRNA的SARS-CoV-2疫苗后的肝损伤
Clin Res Hepatol Gastroenterol. 2022 Jan;46(1):101743. doi: 10.1016/j.clinre.2021.101743. Epub 2021 Jun 16.
4
Sars-Cov-2 vaccination in liver transplant recipients: The 'holy grail' in a hostile environment.肝移植受者的新冠病毒疫苗接种：在不利环境中的“圣杯”。
Liver Int. 2022 Jun;42(6):1225-1228. doi: 10.1111/liv.15226.
5
SARS-CoV-2 vaccination in liver transplant recipients: We still haven't found what we are looking for.肝移植受者接种严重急性呼吸综合征冠状病毒2（SARS-CoV-2）疫苗：我们仍未找到我们所寻找的答案。
Ann Hepatol. 2023 May-Jun;28(3):101081. doi: 10.1016/j.aohep.2023.101081. Epub 2023 Mar 5.
6
Clinical update on the efficacy of anti-SARS-CoV-2 mRNA vaccines in patients on the waiting list for liver transplantation and in liver transplant recipients.抗SARS-CoV-2 mRNA疫苗对肝移植等待名单上的患者及肝移植受者疗效的临床最新情况
Dig Liver Dis. 2021 Oct;53(10):1232-1234. doi: 10.1016/j.dld.2021.07.019. Epub 2021 Jul 29.
7
Use of COVID-19 vaccines in patients with liver disease and post-liver transplantation: Position statement of the Saudi association for the study of liver diseases and transplantation.《沙特肝病研究与移植协会关于肝病和肝移植患者使用 COVID-19 疫苗的立场声明》
Saudi J Gastroenterol. 2021 Jul-Aug;27(4):201-207. doi: 10.4103/sjg.sjg_223_21.
8
Impaired Humoral Response in Renal Transplant Recipients to SARS-CoV-2 Vaccination with BNT162b2 (Pfizer-BioNTech).肾移植受者对 BNT162b2（辉瑞-生物科技）接种 SARS-CoV-2 疫苗的体液免疫反应受损。
Viruses. 2021 Apr 25;13(5):756. doi: 10.3390/v13050756.
9
Impact of Shielding and First Dose of COVID-19 Vaccination in Kidney Transplant Recipients.屏蔽防护和首剂新冠疫苗接种对肾移植受者的影响
Nephron. 2022;146(1):64-66. doi: 10.1159/000518631. Epub 2021 Sep 2.
10
Weak anti-SARS-CoV-2 antibody response after the first injection of an mRNA COVID-19 vaccine in kidney transplant recipients.肾移植受者首次接种mRNA新冠疫苗后抗SARS-CoV-2抗体反应较弱。
Kidney Int. 2021 Jun;99(6):1487-1489. doi: 10.1016/j.kint.2021.03.014. Epub 2021 Mar 26.

引用本文的文献

1
The impact of COVID-19 on liver transplantation: challenges and perspectives.2019年冠状病毒病对肝移植的影响：挑战与展望
Therap Adv Gastroenterol. 2023 May 10;16:17562848231171452. doi: 10.1177/17562848231171452. eCollection 2023.
2
New-onset and relapsed liver diseases following COVID-19 vaccination: a systematic review.新型冠状病毒肺炎疫苗接种后新发和复发肝病：系统评价。
BMC Gastroenterol. 2022 Oct 13;22(1):433. doi: 10.1186/s12876-022-02507-3.
3
Solid Organ Rejection following SARS-CoV-2 Vaccination or COVID-19 Infection: A Systematic Review and Meta-Analysis.

本文引用的文献

1
Italian association for the study of the liver position statement on SARS-CoV2 vaccination.意大利肝脏研究协会关于 SARS-CoV2 疫苗接种的立场声明。
Dig Liver Dis. 2021 Jun;53(6):677-681. doi: 10.1016/j.dld.2021.03.013. Epub 2021 Apr 30.
2
Low immunogenicity to SARS-CoV-2 vaccination among liver transplant recipients.肝移植受者对 SARS-CoV-2 疫苗的免疫原性较低。
J Hepatol. 2021 Aug;75(2):435-438. doi: 10.1016/j.jhep.2021.04.020. Epub 2021 Apr 21.
3
[Not Available].[无可用内容]
严重急性呼吸综合征冠状病毒2（SARS-CoV-2）疫苗接种或新型冠状病毒肺炎（COVID-19）感染后的实体器官排斥反应：一项系统评价和荟萃分析
Vaccines (Basel). 2022 Aug 10;10(8):1289. doi: 10.3390/vaccines10081289.
4
Mycophenolate mofetil decreases humoral responses to three doses of SARS-CoV-2 vaccine in liver transplant recipients.霉酚酸酯降低肝移植受者对三剂 SARS-CoV-2 疫苗的体液反应。
Liver Int. 2022 Aug;42(8):1872-1878. doi: 10.1111/liv.15258. Epub 2022 Apr 2.
5
COVID-19 Vaccine Acceptance among Liver Transplant Recipients.肝移植受者对新冠病毒疫苗的接受情况
Vaccines (Basel). 2021 Nov 11;9(11):1314. doi: 10.3390/vaccines9111314.
6
Protected or not protected, that is the question - First data on COVID-19 vaccine responses in patients with NAFLD and liver transplant recipients.是否受到保护，这就是问题所在——关于非酒精性脂肪性肝病患者和肝移植受者对新冠病毒疫苗反应的首批数据。
J Hepatol. 2021 Aug;75(2):265-266. doi: 10.1016/j.jhep.2021.05.007. Epub 2021 May 25.
Z Gastroenterol. 2021 Apr;59(4):345-359. doi: 10.1055/a-1372-5595. Epub 2021 Apr 12.
4
EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients.EASL 立场文件：关于在慢性肝病、肝胆癌和肝移植受者中使用 COVID-19 疫苗的建议。
J Hepatol. 2021 Apr;74(4):944-951. doi: 10.1016/j.jhep.2021.01.032. Epub 2021 Feb 6.
5
Age and comorbidity are central to the risk of death from COVID-19 in liver transplant recipients.年龄和合并症是肝移植受者因 COVID-19 死亡风险的核心因素。
J Hepatol. 2021 Jul;75(1):226-228. doi: 10.1016/j.jhep.2021.01.036. Epub 2021 Feb 5.
6
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.mRNA-1273 新型冠状病毒疫苗的有效性和安全性。
N Engl J Med. 2021 Feb 4;384(5):403-416. doi: 10.1056/NEJMoa2035389. Epub 2020 Dec 30.
7
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.ChAdOx1 nCoV-19 疫苗（阿斯利康）对 SARS-CoV-2 的安全性和有效性：巴西、南非和英国四项随机对照试验的中期分析。
Lancet. 2021 Jan 9;397(10269):99-111. doi: 10.1016/S0140-6736(20)32661-1. Epub 2020 Dec 8.
8
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.BNT162b2 mRNA 新冠病毒疫苗的安全性和有效性。
N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.
9
A global survey of potential acceptance of a COVID-19 vaccine.一项针对 COVID-19 疫苗潜在接受度的全球调查。
Nat Med. 2021 Feb;27(2):225-228. doi: 10.1038/s41591-020-1124-9. Epub 2020 Oct 20.
10
Determining risk factors for mortality in liver transplant patients with COVID-19.确定感染新型冠状病毒肺炎的肝移植患者的死亡风险因素。
Lancet Gastroenterol Hepatol. 2020 Jul;5(7):643-644. doi: 10.1016/S2468-1253(20)30125-4. Epub 2020 Apr 25.